Endoscopic Submucosal Dissection Market Size Supported by Rising Adoption
Rising Preference for Organ-Preserving Endoscopic Procedures Drives Growth of the Global Endoscopic Submucosal Dissection Market
The global Endoscopic Submucosal Dissection (ESD) Market is witnessing significant expansion due to the rising prevalence of gastrointestinal (GI) cancers, increasing adoption of minimally invasive procedures, and advancements in endoscopic technologies. Endoscopic Submucosal Dissection is a specialized technique used for the en bloc removal of early-stage gastrointestinal tumors, enabling precise resection while preserving healthy tissue and organ function.
The global endoscopic submucosal dissection (ESD) market was valued at USD 369.18 million in 2024. It is projected to reach USD 388.38 million in 2025 and grow to USD 618.18 million by 2034, registering a CAGR of 5.3% during 2025–2034.
Market Overview
Endoscopic Submucosal Dissection has emerged as a preferred treatment option for early-stage gastrointestinal malignancies due to its ability to achieve complete tumor removal without the need for open surgery. The procedure offers several advantages, including reduced hospital stay, lower complication rates, faster recovery, and improved patient outcomes.
Healthcare systems are increasingly shifting toward minimally invasive techniques as part of broader efforts to reduce surgical risks and healthcare costs. The adoption of advanced endoscopic devices, such as high-definition endoscopes, electrosurgical knives, and traction devices, is enhancing procedural efficiency and safety.
The rising geriatric population, which is more susceptible to gastrointestinal disorders and cancers, is also a key factor driving market expansion. Additionally, increased screening programs for colorectal and gastric cancers are leading to earlier diagnosis and higher utilization of ESD procedures.
Technological advancements, including improved visualization systems, artificial intelligence-assisted endoscopy, and enhanced training platforms for endoscopists, are further strengthening market growth. These innovations are enabling greater precision in lesion detection and resection, thereby improving clinical outcomes.
Market Scope
- Rising Incidence of Gastrointestinal Cancers
The increasing global prevalence of gastrointestinal cancers, particularly colorectal and gastric cancers, is driving demand for effective early-stage treatment options. ESD is gaining traction as a preferred method for removing superficial tumors with high precision.
- Shift Toward Minimally Invasive Surgical Procedures
Healthcare providers are increasingly adopting minimally invasive techniques due to their advantages over conventional surgery, including reduced pain, shorter recovery time, and lower healthcare costs. This shift is significantly boosting the adoption of ESD procedures.
- Advancements in Endoscopic Technology
Technological improvements in endoscopic imaging, dissection knives, and hemostatic devices are enhancing the safety and efficiency of ESD procedures. Innovations such as high-definition visualization and robotic-assisted endoscopy are improving procedural outcomes.
- Expansion of Cancer Screening Programs
Government-led and institutional cancer screening initiatives are increasing early detection rates of gastrointestinal lesions. Early diagnosis is a key factor driving the demand for ESD procedures as a curative treatment option for early-stage cancers.
Market Opportunities
- Growing Adoption of AI-Assisted Endoscopy
Artificial intelligence integration in endoscopic systems is creating new opportunities for improved lesion detection, characterization, and procedural guidance. AI-assisted endoscopy enhances diagnostic accuracy and supports better clinical decision-making.
- Increasing Demand for Outpatient Endoscopic Procedures
The shift toward outpatient care settings and ambulatory surgical centers is expanding opportunities for ESD procedures. Shorter hospital stays and reduced healthcare costs are encouraging the adoption of same-day endoscopic treatments.
- Expansion in Emerging Healthcare Markets
Developing regions are witnessing rapid improvements in healthcare infrastructure and increasing access to advanced endoscopic procedures. Rising awareness and growing investments in cancer care are expected to support market growth in these regions.
- Rising Training and Skill Development Programs
The complexity of ESD procedures has led to increased demand for specialized training programs for gastroenterologists. Expansion of simulation-based training and international workshops is improving procedural adoption and outcomes.
Regional Analysis
North America
North America holds a significant share of the Endoscopic Submucosal Dissection Market due to advanced healthcare infrastructure, high awareness of gastrointestinal cancers, and early adoption of minimally invasive technologies. The presence of specialized cancer treatment centers and increasing screening programs further support regional growth.
Europe
Europe represents a strong market driven by well-established healthcare systems and increasing adoption of endoscopic cancer treatment techniques. Government-supported cancer screening initiatives and rising geriatric populations are contributing to steady market expansion.
Asia-Pacific
Asia-Pacific is expected to dominate the global Endoscopic Submucosal Dissection Market during the forecast period. The region has a high prevalence of gastric and esophageal cancers, particularly in countries such as Japan, China, and South Korea, where ESD procedures are widely adopted. Advanced clinical expertise and strong healthcare infrastructure further support regional leadership.
Latin America
Latin America is experiencing gradual growth in the ESD market due to improving healthcare access and increasing awareness of minimally invasive cancer treatments. Expansion of specialized gastroenterology services is contributing to market development.
Middle East & Africa
The Middle East and Africa region is witnessing steady growth driven by improving healthcare infrastructure and rising investments in cancer diagnosis and treatment. Increasing adoption of advanced endoscopic technologies is expected to support future market expansion.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/endoscopic-submucosal-dissection-market
Key Companies
The Endoscopic Submucosal Dissection Market includes leading medical device manufacturers and endoscopy solution providers focusing on innovation, precision instruments, and minimally invasive surgical technologies. Key companies include:
- Olympus Corporation
- FUJIFILM Holdings Corporation
- HOYA Corporation (PENTAX Medical)
- Boston Scientific Corporation
- Medtronic plc
- STERIS plc
- KARL STORZ SE & Co. KG
- CONMED Corporation
- Richard Wolf GmbH
- Cook Medical LLC
These companies are actively investing in advanced endoscopic platforms, high-definition imaging systems, and precision dissection tools to improve procedural efficiency and expand clinical applications of ESD.
Conclusion
The global Endoscopic Submucosal Dissection Market is poised for robust growth as healthcare systems increasingly prioritize minimally invasive cancer treatment options. Rising incidence of gastrointestinal cancers, advancements in endoscopic technologies, and expansion of screening programs are key drivers supporting market expansion.
More Trending Latest Reports By Polaris Market Research:
Abdominal Aortic Aneurysm (AAA) Repair Devices Market